Firm: Linden LlC
Fund Size: $200 million
Fund Name: Linden Capital Partners LP
Target: $150 million
Placement Agent: Park Hill Group
Health care and life sciences specialist
Eric Larson, managing partner and founder at the Chicago firm, says that hefty contributions came from funds-of-funds manager
Linden held a first close on the fund in November 2005 at a little over $100 million, and has since invested “a little over 20%” of the entire pool in three companies. Its first buy, in April of 2005, was of Ranir LLC, an oral health products manufacturer in which Linden bought a controlling interest. The deal was sourced by Linden Operating Partner Mary Beth Pieprzyca. Backer Parish Capital Advisors provided the capital for the transaction through a warehouse facility, and ownership was transferred to the Linden fund last November.
As for investment strategy, Linden favors taking controlling stakes in non-core carveouts from larger companies. Playing liberator, Linden “typically takes captives and makes them independent,” Larson says. Like many GPs responding to demand from limited partners to increase their returns via direct investments, Linden allows for co-investments.
Linden expects to build a portfolio of eight to ten companies, averaging two to three deals per year and writing equity checks of between $15 million and $25 million each. With three investments already complete, the fund should be fully invested in three year’s time. Linden can also tap larger investment opportunities because of its alliance with Madison Dearborn Partners.The firm is looking to close a few transactions in the first quarter, says Larson.
Linden recently added Anthony Kesman, a 30-year health care veteran, to its roster of operating partners. The firm was formed in 2002 by former principals of First Chicago Equity Capital, now One Equity Partners (the private equity arm of JPMorgan.) Mr. Larson is a former managing general partner at First Chicago.—E.B.